Related Experiment Video
Updated: Mar 1, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Thrombectomy Devices in Coronary Intervention
Aaron Horne1, Matthews Chacko1
1Division of Cardiology, Johns Hopkins Hospital, Johns Hopkins University, 1800 Orleans Street, Baltimore, MD 21287, USA.
Insights
Primary percutaneous coronary intervention is the preferred treatment for ST-elevation myocardial infarction (STEMI). Coronary thrombectomy use in STEMI is debated, but recent trials offer new insights for clinical practice.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Primary percutaneous coronary intervention (PCI) is the standard reperfusion therapy for ST-elevation myocardial infarction (STEMI).
- The role of adjunctive coronary thrombectomy in STEMI management remains controversial due to limited historical data.
- Recent trials like TAPAS have influenced the increasing use of thrombectomy in recent years.
Purpose of the Study:
- To examine the existing trial evidence on coronary thrombectomy in STEMI.
- To provide insights into the optimal management and application of thrombectomy in clinical practice.
Main Methods:
- Review of relevant clinical trial evidence.
- Analysis of data from trials including TOTAL, TASTE, and SMART PCI.
- Examination of historical data and recent advancements in thrombectomy use.
Main Results:
- The article synthesizes trial data to evaluate the efficacy and safety of coronary thrombectomy in STEMI.
- Evidence suggests evolving perspectives on thrombectomy's role post-TAPAS trial.
- Ongoing trials (TOTAL, TASTE, SMART PCI) are crucial for definitive conclusions.
Conclusions:
- The optimal role of coronary thrombectomy in STEMI requires careful consideration of current and emerging trial evidence.
- Clinical practice guidelines for STEMI management may be refined based on new data.
- Further research and analysis are essential to standardize thrombectomy application in STEMI patients.
Abstract:
Primary percutaneous coronary intervention is the favored mode of reperfusion therapy for ST-elevation myocardial infarction (STEMI) when able to be performed in a timely fashion in appropriately selected patients. However, controversy about the role of coronary thrombectomy in the management of STEMI persists because of a paucity of favorable historical data. After the TAPAS trial thrombectomy has gained favor in recent years. The results of the TOTAL, TASTE, and SMART percutaneous coronary intervention trials will provide further insight into the use of thrombectomy in STEMI. This article examines the relevant trial evidence regarding how to best manage and apply thrombectomy in clinical practice.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

